An observation, real-life trial to assess vildagliptin, vs oral antihyperglycaemics, in combination with oral antihyperglycaemic monotherapy in patients with type 2 diabetes mellitus inqdeuately controlled with one oral antihyperglycaemic.

Trial Profile

An observation, real-life trial to assess vildagliptin, vs oral antihyperglycaemics, in combination with oral antihyperglycaemic monotherapy in patients with type 2 diabetes mellitus inqdeuately controlled with one oral antihyperglycaemic.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2017

At a glance

  • Drugs Vildagliptin (Primary) ; Antihyperglycaemics
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms EDGE
  • Most Recent Events

    • 13 Jun 2017 Results (n=28442)presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
    • 23 Nov 2014 New trial record
    • 17 Sep 2014 Results of a post-hoc analysis of European patients were presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top